NCT07185919View on ClinicalTrials.gov

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2031

Study Completion Date

September 30, 2031

Conditions
Progressive Familial Intrahepatic Cholestasis
Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT07185919 - A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea | Biotech Hunter | Biotech Hunter